Ectopic Pregnancy of the Tubal Stump in ART Patients, Two Case Reports and a Review of the Literature

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Case Report

iMedPub Journals

2017

Vol.3 No.3:32

Medical Case Reports
ISSN 2471-8041

www.imedpub.com

DOI: 10.21767/2471-8041.100067

Ectopic Pregnancy of the Tubal Stump in ART Paꢀents, Two Case Reports and a Review of the Literature

Piccioni MG1, Riganelli L1*, Donfrancesco C2,3, Savone D1, Caccetta J1, Merlino L1, Mariani M1, Vena F1 and Aragona C1

1Department of Gynecologic-Obstetrical and Urologic Sciences, University of Rome “Sapienza”, Rome, Italy 2Department of Feto-Maternal Medicine, Obstetrics and Gynecology, Portogruaro Hospital, Venice, Italy 3Department of Experimental Medicine, University of Rome “Sapienza”, Rome, Italy *Corresponding author: Riganelli Lucia, MD, Department of Gynecologic-Obstetrical and Urologic Sciences, University of Rome “Sapienza”, Umberto I Policlinico of Rome, Viale del Policlinico 155, 00161 Rome, Italy, Tel: +39 3928994062; E-mail: [email protected]

Rec Date: September 24, 2017, Acc Date: September 29, 2017, Pub Date: September 30, 2017

Citaꢀon: Piccioni MG, Riganelli L, Donfrancesco C, Savone D, Cacceꢀa J, et al. (2017) Ectopic Pregnancy of The Tubal Stump in ART Paꢁents, Two Case Reports and A Review of The Literature. Med Case Rep Vol.3 No.3:32.

Introducꢀon

Ectopic pregnancy represents a potenꢁally serious medical

Abstract

and surgical condiꢁon for women during the reproducꢁve age,

Background: An ectopic pregnancy (EP) is the development of an embryo outside of the uterus. A heterotopic pregnancy (HP) is a mulꢁple pregnancy with different sites of implantaꢁon, where one is intrauterine. These condiꢁons have arisen also by the use of assisted reproducꢁon techniques (ART), in addiꢁon to other causes.

with the possibility to evolve in an emergency obstetrical situaꢁon caused by the rupture and internal bleeding leading to hypovolemic shock and maternal death during the first trimester of gestaꢁon [1,2]. Its reported incidence is around 1.3% to 2% of natural pregnancies [3] and around 1.7% for pregnancies occurring with assisted reproducꢁve technologies (ART), following a recent review performed in the USA [2], and

  • a
  • documented 2.5 to 5-fold increased risk toward

Case presentaꢀon: We consider two cases of intersꢁꢁal

gestaꢁon in paꢁents with previous omolateral salpingectomy for ectopic pregnancies, and a review of the literature. The correct diagnosis was achieved for both paꢁents by the use of ultrasound transvaginal

examinaꢁon.

spontaneously conceived pregnancies [4]. Today the increased incidence of pelvic inflammatory diseases and the higher request to perform ART represents amplificaꢁon risk factors.

The vast majority of ectopic pregnancies (90%) implant occur in the tubal ampulla, while 2.5% of cases are idenꢁfied in the tubal intersꢁꢁal porꢁon. In the vast majority of the cases the embryo prematurely implants itself in the fallopian tube before arriving in the uterine cavity. Only in approximately 2% of the cases EP occur in different regions: cornual, cervical, broad ligament, ovarian, and abdominal. An atypical and insidious severe event is that in which the embryo migrates from the uterine cavity to the contralateral tube [5]. The excepꢁonal anatomic posiꢁon into the tubal stump can result in a delayed idenꢁficaꢁon of EP, increasing the risk of uterine rupture that soars aſter the 12th week of pregnancy.

The first paꢁent received a treatment of methotrexate (MTX) before performing a successful removal of the tubal stump, while the second one was managed directly with

surgery. No postoperaꢁve complicaꢁons occurred and

they were discharged on the second day, postoperaꢁvely. Conclusion: In women with first trimester pregnancy and a reported surgical history of a previous salpingectomy, transvaginal ultrasound examinaꢁon should be performed in order to correctly and promptly idenꢁfy the

implantaꢁon site. When

  • a
  • salpingectomy becomes

Also, a heterotopic pregnancy (HP) is the result of the increased use of ART. HP is a mulꢁple pregnancy with different site of implantaꢁon of embryos: one intrauterine, while the other(s) outside [6]. Infact HP is quite rare among the general populaꢁon (1/7,963-1/30,000) [7], while its incidence in ART pregnancies vary between 1/100 to 1/3,600[8].

necessary, its complete resecꢁon should be performed, in order to prevent or significantly lower an EP occurrence in the tubal stump.

Keywords: Ectopic pregnancy (EP); Assisted reproducꢁve technologies (ART); Tubal stump; Methotrexate (MTX); In

vitro ferꢁlizaꢁon (IVF)

In this case report we illustrate two rare clinical cases of intersꢁꢁal EP occurring into the proximal tubal stump in women subjected to monolateral salpingectomy for a history of ectopic pregnancy. All procedures performed are in accordance with the ethical standards of the insꢁtuꢁonal and

© Copyright iMedPub | This article is available from: http://medical-case-reports.imedpub.com/

1

Medical Case Reports
ISSN 2471-8041

2017

Vol.3 No.3:32

  • naꢁonal research commiꢀee and with the 1964 Helsinki
  • We present also a systemaꢁc revision of intersꢁꢁal

declaraꢁon and its later amendments. Approval and informed pregnancies that occurred in tubal stump Table 1 and a review consent have been obtained from each paꢁent. The about EP in unusual sites in women having had previous Insꢁtuꢁonal Review Board approved this study protocol.

salpingectomies Table 2.

Table 1 Review of literature: intersꢁꢁal pregnancies in tubal stump.

  • Author
  • Year
  • Age
  • Gravity

and parity
Previous history

  • operation
  • Mode

conception

  • of
  • Gestation,

weeks

  • Management
  • Internal

Bleeding

  • Corti [9]
  • 1964
  • -
  • G3, P2
  • Appendicectomy,
  • left
  • Spontaneous
  • 5+3 d
  • Subtotal
  • 50 ml

  • salpingo-oophorectomy
  • hysterectomy

  • for
  • a
  • serous ovarian

cyst

  • Benzi [10]
  • 1967

1968 1998
27 30 36
G2, P0 G2, P2 G4, P0
Righ oophorectomy ectopic pregnancy

  • salpingo-
  • Spontaneous

Spontaneous Spontaneous

  • 5
  • Laparotomic

excision of right tubal stump
Poor None NA for
Krzaniak [11]

Bernardini [12]

  • Appendicectomy,
  • 9
  • Laparotomic

excision of left tubal stump
Ovarian cystectomy

  • Appendicectomy,
  • 4+5 d
  • A
  • single i.m.

dose of MTX (100 mg) on day 61 of gestation

  • Left
  • salpingo-

  • for
  • oophorectomy

interstitial pregnancy tubal

  • Sills [13]
  • 2002

-
39 36
G0, P0 G1, P1
Laparoscopic salpingectomy hydrosalpinx right for
IVF-ET (heterotopic pregnancy)
6+4 d 8
Laparotomic excision of right tubal stump
150 mL

  • 20 mL
  • -
  • Laparotomic
  • right
  • Spontaneous

Spontaneous Spontaneous
Laparoscopic excision of right tubal stump salpingo-oophorectomy for an ovarian dermoid cyst

27

38
G3, P2 G6, P3

  • Laparoscopic
  • right
  • 6
  • Laparoscopic

excision of right tubal stump
100 mL NA salpingo-oophorectomy for ruptured ovarian pregnancy

  • Milingos [14]
  • 2008
  • Laparoscopic

salpingectomy laparoscopic excision of the right tubal stump right and

  • 5+6 d
  • Laparotomic

excision of right tubal stump and left salpingectomy

Faleyimu [15]

Muppala [16]
2008 2009
22 38
G2, P0 G3, P1
Left corneal resection for tubal pregnancy
Spontaneous Spontaneous
56
Laparotomic left salpingooophorectomy
600 mL

  • 500 mL
  • Right salpingectomy for

tubal pregnancy
Laparoscopic cauterisation of

  • right
  • bleeding

tubal stump

Pluchino [17]

Sturlese [18] -
2009 2009 -
34 30 30 40 32
G1, P0 G1, P0 G2, P0 G7, P4 G4, P0
Left salpingectomy for tubal pregnancy
Spontaneous Spontaneous Ovulation induction Ovulation induction IVF-ET
76868
Laparoscopic excision of left tubal stump
1500 mL

  • NA
  • Left
  • salpingo-
  • Laparoscopic

excision of left tubal stump oophorectomy for an ovarian dermoid cyst

  • Laparoscopic
  • right
  • Laparoscopic

excision of right tubal stump
500 mL 550 mL 700 mL salpingectomy for tubal pregnancy

  • Laparoscopic
  • right
  • Laparoscopic

excision of right tubal stump salpingectomy for tubal pregnancy

  • Laparoscopic
  • left
  • Laparoscopic

excision of left tubal stump salpingectomy for tubal pregnancy

This article is available from: http://medical-case-reports.imedpub.com/

2

Medical Case Reports
ISSN 2471-8041

2017

Vol.3 No.3:32

  • 30
  • G3, P0
  • Laparoscopic bilateral

salpingectomy for right ovarian pregnancy and left tubal pregnancy after ICSI

  • ICSI-ET
  • 7
  • Laparotomic

excision of tubal stump
2000 mL
42 32 33
G3, P1 G4, P0 G4, P0
Laparoscopic salpingectomy for tubal pregnancy after IUI

  • left
  • IVF-ET

ICSI-ET IVF-ET

  • 7
  • Laparoscopic

excision of left tubal stump
20 mL
Laparoscopic bilateral salpingectomy bilateral hydrosalpinx

  • 6
  • Laparoscopic

excision of tubal stump
200 mL 100 mL for

  • -
  • -
  • Appendicectomy,
  • 7+1 d
  • Laparoscopic

laparoscopic partial left salpingectomy, excision of left

  • tubal
  • stump

laparoscopic total right salpingectomy
(salpingectomy with cornuostomy).

37

35 33
G0, P0 G0, P0 G11, P3

  • Laparoscopic bilateral
  • IVF-ET
  • 6+2 d
  • Laparoscopic

excision of right tubal stump
Large amount

  • of free fluid
  • salpingectomy
  • for

  • bilateral hydrosalpinx
  • and
  • blood

clots

  • Shavit [19]
  • 2013

2014

  • Laparoscopic bilateral
  • IVF-ET
  • 6
  • Laparoscopic

excision of right tubal stump
Large amount

  • of blood in the
  • salpingectomy
  • for

  • bilateral hydrosalpinx
  • pouch
  • of

Douglas

  • Drakopoulos [20]
  • Laparoscopic

sterilisation by partial bilateral segmental

  • tubal
  • Spontaneous
  • 4+4 d
  • Laparoscopic
  • NA

excision of right tubal stump + a single i.m. dose of MTX 1 mg/kg isthmic salpingectomy

  • -
  • -
  • 21

38

  • G1, P0
  • Tonsillectomy,

laparoscopic salpingectomy for right paratubal cyst torsion

  • Spontaneous
  • 7+3 d
  • Laparoscopic
  • 100 mL

  • right
  • excision of right

tubal stump after tube expression

  • +
  • a
  • single i.m.

dose of MTX mg/kg
1

  • G4, P1
  • Laparoscopic
  • right
  • Spontaneous
  • 5
  • Laparoscopic

excision of right tubal stump+ single i.m. dose of MTX 1 mg/kg
600 mL 600 mL salpingotomy for ectopic pregnancy, laparoscopic right salpingectomy for a

  • another
  • extrauterine

pregnancy

35

27
G6, P1 G0, P0
Laparoscopic bilateral salpingectomy for ectopic pregnancies

  • IVF-ET
  • 6
  • Laparoscopic

bilateral excision of tubal stumps
3

  • Oral [21]
  • 2014
  • bilateral salpingectomy
  • IVF-ET (heterotopic

pregnancy)

  • NA
  • Laparoscopic

excision of right tubal stump
Extensive hemoperitoneum and septum hysteroscopic resection
(bilateral hydrosalpinx + uterine septum), laparoscopic left cornual resection for cornual pregnancy

Abraham [22]

Nishida [23] Xu [24]
2015 2015 2016
27 26 28
G5, P1 G4, P1 G0, P0
Laparoscopic salpingectomy for tubal pregnancy

  • right
  • Spontaneous

Spontaneous IVF-ET
5+6 d 6
Laparoscopic excision of right tubal stump
1500 mL

  • NA
  • Laparoscopic

salpingectomy for tubal pregnancy

  • right
  • Laparoscopic

excision of right tubal stump

  • Bilateral tubal ligation
  • 8+6 d
  • Emergency
  • 500 mL

laparotomic left salpingectomy/ adhesion

© Copyright iMedPub

3

Medical Case Reports
ISSN 2471-8041

2017

Vol.3 No.3:32

decomposition and left ovary repair

  • Iwahashi [25]
  • 2017
  • 26
  • G3, P0
  • right

salpingectomy remnant salpingectomy partial right

  • Spontaneous
  • 6+5 d
  • Emergency

laparotomic left salpingectomy
Massive hemoperitoneum
+

Table 2 Review of literature: EP in unusual sites in women with previous salpingectomies.

  • Author
  • Year
  • Age
  • Gravity and

parity
Previous history

  • operation
  • Type

fecundatio n

  • of
  • Site

pregnancy

  • of
  • ectopic
  • Management

Ferland [26] Fisch [27]
1991 1996
32 38
G4, P0 G2, P0 right salpingectomy for tubal pregnancy
IVF-ET IVF-ET

  • upper retroperitoneum
  • LPTM

  • LPTM
  • LPS
  • (bilateral
  • abdomen (posterior aspect

salpingectomy for two tubal pregnancies)

  • of
  • the
  • right
  • broad

ligament)

  • -
  • -
  • 28

33

  • G0
  • LPS

salpingectomy hydrosalpinx)
(bilateral for
IVF-ET IVF-ET right uterine cornu left uterine cornu
LPTM

  • LPTM
  • G1, P0
  • right salpingectomy for

hydrosalpinx, right tuboplasty, successively left salpingectomy for tubal pregnancy)

32

34
G0 G0 bilateral tuboplasty for tubal disease
IVF-ET IVF-ET right uterine cornu head of pancreas
LPTM

  • LPTM
  • Dmowsky

[28]
2002 2003 2005 2011 2016
LPS salpingectomy hydrosalpinx)
(bilateral for

Cormio [29]

Hsu [30]
30 29 26 28
G2, P0 G0

  • LPS
  • (bilateral
  • IVF-ET

IVF-ET IVF-ET abdomen (lower end of the omentum, adherent to the uterine fundus and cecum)
LPTM salpingectomy for two tubal pregnancies)

LPS salpingectomy hydrosalpinx)
(bilateral for ovary ovary Ovary
MTX and LPS

  • LPS
  • Cruciani [31]

Xu [24]

  • G0
  • LPS

salpingectomy hydrosalpinx)
(bilateral for

  • G3, P0
  • LPS (right salpingectomy

for 2 ectopic pregnancies +left salpingectomy for hydrosalpinx)
IVF-ET (heterotopic pregnancy)
LPTM

accordance with the paꢁent’s desire, using the single dose i.m. MTX regimen (50 mg/m2). Four days aſter treatment the paꢁent complained sudden lower abdominal pain and weakness, that were associated with low blood pressure and severe anemia (Hb 8 g/dL). An operaꢁve laparoscopy was performed with excision of the right tubal stump. Histological

examinaꢁon confirmed the diagnosis of ectopic intersꢁꢁal

pregnancy of the right tubal stump. Intraperitoneal blood collected was around 700 mL. The paꢁent was discharged on day 2 postoperaꢁvely and no short or long-term complicaꢁons were reported.

Case Presentaꢀon

Case 1

A 36-year-old paꢁent, gravida-1 para-0, referred to our

Recommended publications
  • What Is the Effectiveness of Salpingectomy Compared with Salpingotomy in Improving Outcomes in Women with Tubal Ectopic Pregnancy?

    What Is the Effectiveness of Salpingectomy Compared with Salpingotomy in Improving Outcomes in Women with Tubal Ectopic Pregnancy?

    Ectopic pregnancy and miscarriage What is the effectiveness of salpingectomy compared with salpingotomy in improving outcomes in women with tubal ectopic pregnancy? Study details Participants Interventions Methods Outcomes and Results Comments Full citation Sample size Interventions Details Results Limitations Tahseen,S., Wyldes,M., A N=150 Salpingectomy This is a retrospective study Spontaneous intrauterine Retrospective comparative case- (n=97) carried out in the East pregnancy rate (number/total controlled study of Characteristics Birmingham Hospitals (%)) Not reported whether women laparoscopic vs Salpingotomy (Teaching) NHS Trust, UK. were trying to conceive laparotomy management (n=25) All patients operated on Salpingectomy: 38/97 (39.2) of ectopic pregnancy: an Not reported separately for laparoscopically for EP Salpingotomy: 12/25 (48) Outcome of intrauterine evaluation of reproductive salpingectomy and during the study period were pregnancy is not reported performance after radical salpingotomy groups identified. A control group vs conservative treatment was selected randomly from Unclear how fertility data was of tubal ectopic pregnancy, Inclusion criteria those operated on by obtained Journal of Obstetrics and laparotomy. Hospital case Gynaecology, 23, 189-190, Ectopic pregnancy notes were reviewed for Generally poor methodological 2003 details. An attempt was reporting made to contact all patients Ref Id Exclusion criteria regarding contraceptive use. No baseline characteristics Only one spontaneous IUP reported for salpingectomy vs. 69637 Not reported or EP was included per salpingotomy groups patient in the analysis. Country/ies where the Subsequent fertility was Unexplained missing data from study was carried out analysed in relation to initial 28/150 women treatment method and the UK state of the contralateral Blinding of participants and/or tube.
  • Salpingectomy Before Assisted Reproductive Technologies

    Salpingectomy Before Assisted Reproductive Technologies

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Noventa et al. Journal of Ovarian Research (2016) 9:74 DOI 10.1186/s13048-016-0284-1 REVIEW Open Access Salpingectomy before assisted reproductive technologies: a systematic literature review Marco Noventa1, Salvatore Gizzo1, Carlo Saccardi1, Shara Borgato1, Amerigo Vitagliano1, Michela Quaranta2, Pietro Litta1, Michele Gangemi1, Guido Ambrosini1, Donato D’Antona1 and Stefano Palomba3* Abstract Salpingectomy is largely used in case of hydrosalpinx in infertile women scheduled for assisted reproductive technologies (ART), whereas there is no consensus on its role in absence of hydrosalpinx. The current is a systematic literature review to collate all available evidence regarding salpingectomy as fertility enhancement procedure before ART in infertile patients. Our primary endpoint was to assess the impact of the surgical procedure on ovarian reserve, and secondary outcomes were to evaluate its benefits and harms on ART outcomes. We identified 29 papers of which 16 reporting data on the impact of tubal surgery on ovarian reserve and 24 (11 previously included) on ART outcomes. Available data suggested an absence of variation in ovarian reserve markers after unilateral salpingectomy while contradictory results were reported for bilateral surgery. Considering ART outcomes, data reported a significant improvement in ongoing pregnancy/live-birth rate in treated subjects without significant reduction in ovarian response to gonadotropin stimulation. In case of tubal disease, a surgical approach based on unilateral salpingectomy may be considered safe, without negative effects on ovarian reserve and ovarian response to controlled ovarian stimulation whilst having a positive effect on pregnancy rate.
  • In Vitro Fertilization and Embryo Transfer As a Treatment for Infertility

    In Vitro Fertilization and Embryo Transfer As a Treatment for Infertility

    Alberta Heritage Foundation for Medical Research In vitro fertilization and embryo transfer as a treatment for infertility Paula Corabian March 1997 HTA 3 In vitro fertilization and embryo transfer as a treatment for infertility Paula Corabian March 1997 © Copyright Alberta Heritage Foundation for Medical Research, 1997 This Health Technology Assessment Report has been prepared on the basis of available information of which the Foundation is aware from public literature and expert opinion, and attempts to be current to the date of publication. It has been externally reviewed. Additional information and comments relative to the Report are welcome, and should be sent to: Director, Health Technology Assessment Alberta Heritage Foundation for Medical Research 3125 ManuLife Place, 10180 - 101 Street Edmonton Alberta T5J 3S4 CANADA Tel: 403-423-5727, Fax: 403-429-3509 ISBN 0-9697154-3-9 Alberta's health technology assessment program has been established under the Health Research Collaboration Agreement between the Alberta Heritage Foundation for Medical Research and the Alberta Health Ministry. Acknowledgments The Alberta Heritage Foundation for Medical Research is most grateful to the following persons for their comments on the draft report and for provision of information. Dr. K. J. Collier, Manitoba Health, Winnipeg. Dr. D. Cow, Health Insurance and Related Programs, Ministry of Health, Kingston, Ontario. Professor S. Daya, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario. Dr. J. Jarrell, Foothills Hospital, Calgary, Alberta. Dr. M. van Leeuwen, Health Council of the Netherlands, Rijswijk. Professor D. G. Moores, Faculty of Medicine, University of Alberta, Edmonton, Dr. M. Y. Pelletier, Régie de l’assurance-maladie du Québec, Montreal.
  • Renaissance of Surgical Recanalization for Proximal

    Renaissance of Surgical Recanalization for Proximal

    Original Article Renaissance of Surgical Recanalization for Proximal Fallopian Tubal Occlusion: Falloposcopic Tuboplasty as a Promising Therapeutic Option in Tubal Infertility Yudai Tanaka, MD, PhD*, Hiroto Tajima, MD, PhD, Shino Sakuraba, MD, Rise Shimokawa, MD, and Kazuhiko Kamei, MD From the Department of Obstetrics and Gynecology, Shonan IVF Clinic, Kanagawa, Japan (all authors). ABSTRACT Study Objective: To assess the clinical effectiveness of falloposcopic tuboplasty in tubal infertility. Design: Retrospective cohort study (Canadian Task Force classification II-3). Setting: Infertility clinic. Patients: Three hundred forty-five infertile patients (R2y) with a diagnosis of proximal tubal occlusion, either bilateral or unilateral, between January 2005 and January 2011. Intervention: Falloposcopic tuboplasty. Measurements and Main Results: Medical records for 345 patients with a diagnosis of proximal tubal occlusion were re- viewed. Of the 345 patients, 304 underwent falloposcopic tuboplasty, with successful recanalization achieved in 248 patients (81.6%). Ninety-one of the 304 patients (29.9%) became pregnant. Of these, 18 patients (19.8%) miscarried, and 4 (4.4%) had ectopic pregnancies in the recanalized tube. At 1-, 3-, 6-, and 9-month follow-up, the cumulative probability of conception was 23.1%, 50.6%, 73.6%, and 82.4%, respectively. Related complications included postsurgical infection (0.3%), perforation of the fallopian tube (1.3%), and accidental breakage of the catheter (4.9%) or the falloposcope (1.3%). Conclusions: Falloposcopic tuboplasty is safe and effective for treatment of tubal infertility. The pregnancy rate after fallo- poscopic tuboplasty is comparable to that after in vitro fertilization, which suggests that it can be an alternative to in vitro fertilization in women with tubal infertility.
  • Infertility Services

    Infertility Services

    Medical Coverage Policy Effective Date ............................................. 6/15/2021 Next Review Date ....................................... 6/15/2022 Coverage Policy Number .................................. 0089 Infertility Services Table of Contents Related Coverage Resources Overview .............................................................. 1 Acupuncture Coverage Policy ................................................... 1 Genetic Testing for Reproductive Carrier Screening General Background ............................................ 5 and Prenatal Diagnosis Medicare Coverage Determinations .................. 21 Hyperbaric Oxygen Therapy, Systemic & Topical Coding/Billing Information .................................. 21 Infertility Injectables References ........................................................ 29 Recurrent Pregnancy Loss: Diagnosis and Treatment Testosterone Therapy INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary
  • Reproductive Surgery in the Era of ART (Didactic)

    Reproductive Surgery in the Era of ART (Didactic)

    Reproductive Surgery in the Era of ART (Didactic) PROGRAM CHAIR William W. Hurd, MD G. David Adamson, MD Victor Gomel, MD Keith B. Isaacson, MD Sponsored by AAGL Advancing Minimally Invasive Gynecology Worldwide Professional Education Information Target Audience Educational activities are developed to meet the needs of surgical gynecologists in practice and in training, as well as, other allied healthcare professionals in the field of gynecology. Accreditation AAGL is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AAGL designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS As a provider accredited by the Accreditation Council for Continuing Medical Education, AAGL must ensure balance, independence, and objectivity in all CME activities to promote improvements in health care and not proprietary interests of a commercial interest. The provider controls all decisions related to identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the activity. Course chairs, planning committee members, presenters, authors, moderators, panel members, and others in a position to control the content of this activity are required to disclose relevant financial relationships with commercial interests related to the subject matter of this educational activity. Learners are able to assess the potential for commercial bias in information when complete disclosure, resolution of conflicts of interest, and acknowledgment of commercial support are provided prior to the activity.
  • Falloposcopy--A Prerequisite to the Proper Assessment of Tubal Infertility

    Falloposcopy--A Prerequisite to the Proper Assessment of Tubal Infertility

    Wong et al REVIEW ARTICLES Falloposcopy—aprerequisitetotheproperassessment oftubalinfertility AYKWong,SMWalker Objective. To review the technique and results of falloposcopy, and the classification and management of fallopian tube disease. Data sources. Medline and non-Medline search of the relevant English literature, and personal experience. Study selection. Studies involving the use of falloposcopy to assess tubal status were selected for review. Data extraction. The procedure of falloposcopy and its possible problems and complications were studied. Results from falloposcopy were compared with those from conventional investigations of tubal status, and their correlation with pregnancy was evaluated. Data synthesis. Falloposcopy gives a better assessment of tubal status than conventional methods and can also predict the subsequent pregnancy rate. By falloposcopy, the decision of the mode of therapy for subfertility can be changed in more than 60% of patients. Conclusion. Examination of the fallopian tube using falloposcopy allows an accurate assessment of the tubal status to be made and is a prerequisite to deciding the most appropriate mode of assisted reproductive therapy. HKMJ 1999;5:76-81 Key words: Fallopian tube diseases/diagnosis; Fallopian tube disease/therapy; Infertility, female Introduction outcome of treatment such as tubal surgery is related to tubal status.4 By the more accurate assessment of Fallopian tube disease accounts for more than 30% of the endotubal status using transcervical falloposcopy, female subfertilities.1 In the investigation of tubal infer- patients can be triaged to the most appropriate mode tility, the goal must be to test the function of the fallo- of therapy to maximise pregnancy rates. This review pian tubes rather than to demonstrate their patency.1 describes the pitfalls of the conventional methods of Conventional methods used in tubal assessment, assessing tubal patency, and the technical aspects of such as hysterosalpingography (HSG) or laparoscopic and results from transcervical falloposcopy.
  • Hydrosalpinx and IVF: a Randomized Study (192 Cases)

    Hydrosalpinx and IVF: a Randomized Study (192 Cases)

    Togas Tulandi Department of Obstetrics and Gynecology McGill University Montreal, Quebec, Canada Declared receipt of honoraria or consultation fees by Ethicon Inc. What is left of Reproductive Surgery? Togas Tulandi MD, MHCM Professor of Obstetrics and Gynecology & Milton Leong Chair in Reproductive Medicine McGill University Redefining Reproductive Surgery Togas Tulandi MD, MHCM Professor of Obstetrics and Gynecology & Milton Leong Chair in Reproductive Medicine McGill University Vi ringrazio per avermi invitato a Milano What is Reproductive Surgery? • Surgery to correct anatomical disorders of the reproductive tract. • In practice, it has been limited to primary treatment of infertility for women with tubal disorders or endometriosis. Case 1 A 26 year old woman 5 IVFs and one miscarriage I. Reproductive Surgery as a primary treatment Pregnancy rate 12 mths after surgery • Adhesiolysis: 40% • Salpingostomy: 30.% • Endometriosis: 30.7% • Tubal anastomosis: 79.4% • IVF: 40.6% per cycle, ectopic rate 1.8% Procedure Authors No. Intra-uterine Ectopic rate rate Neo-salpingostomy Canis et al 87 33.3% 6.9% Fimbrioplasty Saleh & Dlugi 88 35% 1% Tubal anastomosis Yoon et al 186 79.4% 3.2% Ablation of state I & II Marcoux et al 172 30.7% 4% endometriosis Parazzini 51 23.5% 0% Excision of Beretta et al 32 50%* NA endometrioma Alborzi et al 52 59.4%* NA Fenestration Beretta et al 32 15%* NA Alborzi et al 48 23.3%* NA IVF Authors No. PR per transfer Ectopic rate SART 2007 67,922 40.6% 1.8% Reproductive Surgery as a primary treatment 1. The place of reproductive surgery as a primary treatment of infertility is limited 2.
  • Management of Tubal Obstructions

    Management of Tubal Obstructions

    ______________________________________________________________________________ Management of Tubal Obstructions Diaa M. El-Mowafi Professor, Department of Obstetrics and Gynaecology, Benha Faculty of Medicine, Egypt Researcher and Educator, W ayne State University, MI, USA Fellow and Lecturer, Geneva University, Switzerland Consultant and Head of Obstetrics & Gynecology Department, King Khalid General Hospital, Hafr El-Batin, Saudi Arabia Nkele Ndeki Ngoh Registrar, Geneva University, Switzerland Direct Correspondence To: Dr. Diaa El-Mowafi Consultant and Head Department of Obstetrics & Gynecology King Khalid General Hospital Hafr Al-Batin 31991 Saudi Arabia dmowafi@ yahoo.com How to cite this article: El Mowafi DM, Ngo NN. Management of Tubal Obstructions. Geneva Foundation for Medical Education and Research. 15 Nov. 2006. Available from: http://www.gfmer.ch/Presentations_En/Pdf/Tubal_obstruction_Mowafi_2006.pdf 2 BSTRACT Management of the tubal factor could have the most difficult and debatable role in infertility management. The methods used ranged from gaseous insufflation, hydrotubation, laparotomy, and traditional microsurgery to the more recent tactile or hysteroscopic catheterization, and laparoscopic surgery. Results of the in-vitro-fertilization-embryo transfer (IVF-ET) or intracytoplasmic sperm injection (ICSI) were compared to the surgical procedures' results and the debate continues: shall we proceed directly to assisted reproductive techniques or should surgery be tried first in tubal obstructions? 3 INTRODUCTION Fallopian tube disease is responsible for more than 20% to 30% of female infertility worldwide (1). The lesions range from intrinsic intraluminal malformation of cilia, mucosa, or muscularis, to gross occlusion of the lumen. Tubal obstruction has preoccupied many gynaecologists for centuries. Its importance as a major cause of infertility was recognised by Burns in 1809 (2).
  • Tubal Stump Pregnancy in ART Patients Two Cases of Ectopic Stump Pregnancy After IVF-ET

    Tubal Stump Pregnancy in ART Patients Two Cases of Ectopic Stump Pregnancy After IVF-ET

    ISSN: 2574-1241 Volume 5- Issue 4: 2018 DOI: 10.26717/BJSTR.2018.10.002026 Chiara Di Tucci. Biomed J Sci & Tech Res Case Report Open Access Tubal Stump Pregnancy in ART Patients Two cases of ectopic stump pregnancy after IVF-ET Di Tucci Chiara*, Schiavi Michele Carlo, Iacobelli Valentina, Donfrancesco Cristina, Piccioni Maria Grazia, Perniola Giorgia, Muzii Ludovico and Benedetti Panici Pierluigi Department of Gynecologic-Obstetrical and Urologic Sciences, Italy Received: Published: *Corresponding: Octobet author: 22, 2018; : November 13, 2018 Chiara Di Tucci, Department of Obstetrics and Gynecology, Italy Abstract Ectopic pregnancy (EP) is a complication of pregnancy in which the embryo attaches outside the uterus. The rate of ectopic pregnancy is about 1 and 2% that of live births, though it may be as high as 4% among those using assisted reproductive technology (ART). We present two cases of interstitial stump pregnancies in patients who previously underwent salpingectomy for ectopic pregnancies, and a review of the literature. One patient has been treated with methotrexate (MTX) before the removal of the tubal stump, while the second has gone directly to laparoscopic (LPS) surgery. Transvaginal ultrasound examination is essential for early and accurate management of this condition. It should be quickly performed to rule out a stump interstitial pregnancy in women who conceive by ART after bilateral salpingectomy. A correct attitude towards this condition is not yetKeywords: internationally standardized and both medical and surgical options should be promptly considered. In vitro Abbreviations:Ectopic pregnancy (EP); Assisted reproductive technologies (ART); Tubal stump; Methotrexate (MTX); In fertilization Vitro (IVF) EP: Ectopic Pregnancy; ART: Assisted Reproductive Technologies; MTX: Tubal Stump Methotrexate; IVF: Fertilization Introduction Ectopic pregnancies (EP) represent the most serious occurred in a fallopian stump after in vitro to the contralateral tube.
  • IFFS Guidelines: Tubal Surgery

    IFFS Guidelines: Tubal Surgery

    International Federation of Fertility Societies Global Standards of Infertility Care Standard 9 Tubal Surgery Recommendations for Practice Name Tubal surgery Version number 9.1/IFFS/Standards Author Standards and Practice Committee, Lead author - Ossie Petrucco. Date of first release 20th October 2011 Date approved by IFFS 16th October 2011 Date of review October 2015 Introduction The goal of IFFS Practice Standards are to provide policy- and decision-makers and the clinical and scientific community with a set of recommendations that can be used as a basis for developing or revising institutional or national guidelines on selected practice recommendations for infertility practice. The document addresses minimal standards of practice but does not provide rigid guidelines but rather gives recommendations that provide the basis for rationalizing the provision of infertility services in view of the most up-to-date information available. Because country situations and programme environments vary so greatly, it is inappropriate to set firm international guidelines on infertility practice. However, it is expected that institutional and national programmes will use these guidance documents for updating or developing their own infertility guidelines in the light of their national health policies, needs, priorities and resources. The intent is to help improve access to, quality of, and safety of infertility and assisted conception services. These improvements must be made within the context of users’ informed Tubal Surgery 9.1/IFFS/Standards and Practice/July 2014 Page 1 choice and medical safety. Adaptation is not always an easy task and is best done by those well-acquainted with prevailing health conditions, behaviours, and cultures.